+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Research Antibodies Market By Product, By Antibody Type, By Technology, By Application, By End-Users, 2017-2027

  • ID: 5206622
  • Report
  • October 2020
  • Region: Global
  • 269 pages
  • Reports and Data

FEATURED COMPANIES

  • Abcam PLC
  • Agilent Technologies
  • Becton
  • Bio-Rad Laboratories
  • Dickinson Co.pany
  • F.Hoffmann-La Roche AG
A significant rise in research activities in the field of stem cells and neurobiology is one of the key factors stimulating the growth of the market.

Market Size - USD 3.35 Billion in 2019, Market Growth - CAGR of 5.9%, Market Trends - Increased funding for research and development activities

The Global Research Antibodies Market size was valued at USD 3.35 Billion in 2019 and is forecast to reach USD 5.33 Billion, exhibiting a CAGR of 5.9% through 2027, according to the latest report. Market growth is driven by a rise in research activities in the field of stem cells, along with the growing prevalence of neurological and blood disorders. The WHO estimates that nearly 27 million babies across the globe are born with some blood disorder. As of 2008, there were approximately 100,000 children suffering from thalassemia, an inherited blood disorder, in India alone.

Stem cell therapies are gaining massive popularity as they offer the potential for discerning and regenerating new cells in the human body, thereby curing or lessening the effect of life-threatening diseases like oncological and blood-related disorders. The cord blood stem cells offer the potential to treat over 80 blood-related ailments, such as leukemia, lymphomas, sickle cell disease, and others.

The rise in funding for R&D activities is positively impacting the research antibodies market. Over 2014 and 2017, the investment in healthcare R&D by the United States has witnessed a growth of 18.1%. Moreover, in 2017, the overall expenditure on healthcare R&D was USD 182.30 billion. The growing modality rate of cancer and other deadly diseases and demand for high-quality antibodies for research reproducibility will foster research antibodies market share over the forecast period.

Further key findings from the report suggest
  • Based on product type, the primary antibodies segment is forecast to grow at a CAGR of 6.2% over the analysis period. In immunoassays, primary antibodies are of major importance to bind to the target antigen.
  • On the basis of technology, the western blotting segment is set to witness major gains over the forecast period on account of its capacity to detect picogram levels of protein in a sample, making it ideal for use in several applications as an effective early diagnostic tool. Additionally, it enables researchers to direct label primary antibodies, thereby eliminating the requirement for secondary antibodies.
  • Based on application, the oncology segment contributed significantly to the market revenue share in 2019 and is expected to grow at a CAGR of 5.7% over the analysis period.
  • In terms of end-use, the academics & research institutes segment held the second-largest market share of the research antibodies industry in 2019 and are likely to exhibit a CAGR of 5.2% through 2027.
  • In the regional landscape, the Asia Pacific region is anticipated to experience the fastest growth rate of 7.1% through 2027 on account of the growth of the pharmaceutical industry, acceptance of innovative methods for antibody production, and surge in R&D activities for antibodies in the region, among others.
  • Europe held the second-largest share in the research antibodies market share in 2019 and is forecast to exhibit a CAGR of 5.7% through 2027.
  • North America is estimated to showcase a notable CAGR of 5.2% over the forecast period on account of the growing prevalence of blood diseases and neurological diseases, increased investment in medical R&D activities, technological advancements in proteomics research, growing demand for personalized medicine, and the presence of leading market players in the region.
  • Prominent players in the global antibodies market are Becton, Lonza Group, Agilent Technologies, Dickinson and Company, Abcam PLC, Bio-Rad Laboratories, PerkinElmer, Inc., Merck Millipore, Thermo Fisher Scientific, Cell Signaling Technology Inc., and F.Hoffmann-La Roche AG, among others.
  • Abcam PLC, a leading supplier of protein research tools, made an announcement in January 2020 regarding the acquisition of the Immunology & Proteomics business of Expedeon Ltd., comprising of TGR Biosciences and Innova.
For the purpose of this report, Reports and Data has segmented the Global Research Antibodies Market on the basis of product, antibody type, technology, application, industry vertical, and region:

Product Outlook (Revenue, USD Million; 2017-2027)
  • Primary Antibodies
  • Secondary Antibodies
Antibody Type Outlook (Revenue, USD Million; 2017-2027)
  • Monoclonal
  • Polyclonal
Technology Outlook (Revenue, USD Million; 2017-2027)
  • Western Blotting
  • Flow Cytometry
  • Immunofluorescence
  • Immunohistochemistry
  • Enzyme-linked Immunosorbent Assay
  • Immunoprecipitation
  • Others
Application Outlook (Revenue, USD Million; 2017-2027)
  • Oncology
  • Infectious Diseases
  • Stem Cells
  • Neurobiology
  • Immunology
  • Others
Industry Vertical Outlook (Revenue, USD Million; 2017-2027)
  • Pharmaceutical & Biopharmaceutical
  • Academic & Research Institutes
  • Contract Research Organizations
Regional Outlook (Revenue, USD Million; 2017-2027)
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Benelux
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Reasons to Buy the Report
  • A robust analysis and estimation of the Research Antibodies Market with four levels of quality check - in-house database, expert interviews, governmental regulation, and a forecast specifically done through time series analysis
  • A holistic competitive landscape of the all the major players in the Research Antibodies market. The report covers their market shares, strategic initiatives, new product launches, R&D expenditure, M&As, Joint ventures, expansionary plans, product wise metric space analysis and key developments
  • Go-to-market strategies specifically formulated in line with location analysis which takes into the factors such as government regulations, supplier mapping, supply chain obstacles, and feedback from local vendors
  • Most deep dive segmental bifurcation available currently in the market. Our stellar methodology helps us understand the overall gamut of the supply chain and will help you explain the current market dynamics
  • Special focus given on vendor landscape, supplier portfolio, customer mapping, production capacity, and yearly capacity utilization
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abcam PLC
  • Agilent Technologies
  • Becton
  • Bio-Rad Laboratories
  • Dickinson Co.pany
  • F.Hoffmann-La Roche AG
Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique

Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027

Chapter 3. Indicative Metrics

Chapter 4. Research Antibodies Segmentation & Impact Analysis
4.1. Research Antibodies Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Surge in research activities in the field of Neurobiology and stem cells
4.2.2.2. Growth of the biopharmaceutical industry
4.2.2.3. Increased funding for research and development activities
4.2.3. Market restraints analysis
4.2.3.1. Cost prohibitive Research Antibodies
4.3. Technological Insights
4.4. Regulatory Framework
4.5. ETOP Analysis
4.6. Porter’s Five Forces Analysis
4.7. Competitive Metric Space Analysis
4.8. Price trend Analysis
4.9. Customer Mapping
4.10. Covid-19 Impact Analysis
4.11. Global Recession Influence

Chapter 5. Research Antibodies Market By Product Insights & Trends
5.1. Product dynamics & Market Share, 2020 & 2027
5.2. Primary Antibodies
5.2.1. Market estimates and forecast, 2017 - 2027 (USD Million)
5.2.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
5.3. Secondary Antibodies
5.3.1. Market estimates and forecast, 2017 - 2027 (USD Million)
5.3.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)

Chapter 6. Research Antibodies Market By Antibody Type Insights & Trends
6.1. Antibody Type Dynamics & Market Share, 2020 & 2027
6.2. Monoclonal
6.2.1. Market estimates and forecast, 2017 - 2027 (USD Million)
6.2.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
6.3. Polyclonal
6.3.1. Market estimates and forecast, 2017 - 2027 (USD Million)
6.3.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)

Chapter 7. Research Antibodies Market By Technology & Trends
7.1. Technology Dynamics & Market Share, 2020 & 2027
7.2. Western Blotting
7.2.1. Market estimates and forecast, 2017 - 2027 (USD Million)
7.2.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
7.3. Flow Cytometry
7.3.1. Market estimates and forecast, 2017 - 2027 (USD Million)
7.3.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
7.4. Immunofluorescence
7.4.1. Market estimates and forecast, 2017 - 2027 (USD Million)
7.4.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
7.5. Immunohistochemistry
7.5.1. Market estimates and forecast, 2017 - 2027 (USD Million)
7.5.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
7.6. Enzyme-Linked Immunosorbent Assay
7.6.1. Market estimates and forecast, 2017 - 2027 (USD Million)
7.6.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
7.7. Immunoprecipitation
7.7.1. Market estimates and forecast, 2017 - 2027 (USD Million)
7.7.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
7.8. Others
7.8.1. Market estimates and forecast, 2017 - 2027 (USD Million)
7.8.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)

Chapter 8. Research Antibodies Market By Application Insights & Trends
8.1. Application Dynamics & Market Share, 2020 & 2027
8.2. Oncology
8.2.1. Market estimates and forecast, 2017 - 2027 (USD Million)
8.2.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
8.3. Infectious Diseases
8.3.1. Market estimates and forecast, 2017 - 2027 (USD Million)
8.3.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
8.4. Stem Cells
8.4.1. Market estimates and forecast, 2017 - 2027 (USD Million)
8.4.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
8.5. Neurobiology
8.5.1. Market estimates and forecast, 2017 - 2027 (USD Million)
8.5.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
8.6. Immunology
8.6.1. Market estimates and forecast, 2017 - 2027 (USD Million)
8.6.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
8.7. Others
8.7.1. Market estimates and forecast, 2017 - 2027 (USD Million)
8.7.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)

Chapter 9. Research Antibodies Market By End-Users Insights & Trends
9.1. End-Users Dynamics & Market Share, 2020 & 2027
9.2. Pharmaceutical & Biotechnological Industry
9.2.1. Market estimates and forecast, 2017 - 2027 (USD Million)
9.2.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
9.3. Academic & Research Institutes
9.3.1. Market estimates and forecast, 2017 - 2027 (USD Million)
9.3.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
9.4. Contract Research Organizations
9.4.1. Market estimates and forecast, 2017 - 2027 (USD Million)
9.4.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)

Chapter 10. Research Antibodies Market Regional Outlook
10.1. Research Antibodies Market share by region, 2020 & 2027
10.2. North America
10.2.1. Covid-19 Impact Analysis, 2020-2021
10.2.2. Global Recession Influence, 2020-2021
10.2.3. North America Research Antibodies Market estimates and forecast, 2017 - 2027, (USD Million)
10.2.4. North America Research Antibodies Market estimates and forecast By Product, 2017 -2027, (USD Million)
10.2.5. North America Research Antibodies Market estimates and forecast by Antibody Type, 2017 -2027, (USD Million)
10.2.6. North America Research Antibodies Market estimates and forecast by Technology, 2017 -2027, (USD Million)
10.2.7. North America Research Antibodies Market estimates and forecast by Application, 2017 -2027, (USD Million)
10.2.8. North America Research Antibodies Market estimates and forecast by End-Users, 2017 -2027, (USD Million)
10.2.9. U.S.
10.2.9.1. U.S. Research Antibodies Market estimates and forecast, 2017 - 2027, (USD Million)
10.2.9.2. U.S. Research Antibodies Market estimates and forecast By Product, 2017 -2027, (USD Million)
10.2.9.3. U.S. Research Antibodies Market estimates and forecast by Antibody Type, 2017 -2027, (USD Million)
10.2.9.4. U.S. Research Antibodies Market estimates and forecast by Technology, 2017 -2027, (USD Million)
10.2.9.5. U.S. Research Antibodies Market estimates and forecast by Application, 2017 -2027, (USD Million)
10.2.9.6. U.S. Research Antibodies Market estimates and forecast by End-Users, 2017 -2027, (USD Million)
10.2.10. Canada
10.2.10.1. Canada Research Antibodies Market estimates and forecast, 2017 - 2027, (USD Million)
10.2.10.2. Canada Research Antibodies Market estimates and forecast By Product, 2017 -2027, (USD Million)
10.2.10.3. Canada Research Antibodies Market estimates and forecast by Antibody Type, 2017 -2027, (USD Million)
10.2.10.4. Canada Research Antibodies Market estimates and forecast by Technology, 2017 -2027, (USD Million)
10.2.10.5. Canada Research Antibodies Market estimates and forecast by Application, 2017 -2027, (USD Million)
10.2.10.6. Canada Research Antibodies Market estimates and forecast by End-Users, 2017 -2027, (USD Million)
10.3. Europe
10.3.1. Covid-19 Impact Analysis, 2020-2021
10.3.2. Global Recession Influence, 2020-2021
10.3.3. Europe Research Antibodies Market estimates and forecast, 2017 - 2027, (USD Million)
10.3.4. Europe Research Antibodies Market estimates and forecast By Product, 2017 -2027, (USD Million)
10.3.5. Europe Research Antibodies Market estimates and forecast by Antibody Type, 2017 -2027, (USD Million)
10.3.6. Europe Research Antibodies Market estimates and forecast by Technology, 2017 -2027, (USD Million)
10.3.7. Europe Research Antibodies Market estimates and forecast by Application, 2017 -2027, (USD Million)
10.3.8. Europe Research Antibodies Market estimates and forecast by End-Users, 2017 -2027, (USD Million)
10.3.9. Germany
10.3.9.1. Germany Research Antibodies Market estimates and forecast, 2017 - 2027, (USD Million)
10.3.9.2. Germany Research Antibodies Market estimates and forecast By Product, 2017 -2027, (USD Million)
10.3.9.3. Germany Research Antibodies Market estimates and forecast by Antibody Type, 2017 -2027, (USD Million)
10.3.9.4. Germany Research Antibodies Market estimates and forecast by Technology, 2017 -2027, (USD Million)
10.3.9.5. Germany Research Antibodies Market estimates and forecast by Application, 2017 -2027, (USD Million)
10.3.9.6. Germany Research Antibodies Market estimates and forecast by End-Users, 2017 -2027, (USD Million)
10.3.10. U.K.
10.3.10.1. U.K. Research Antibodies Market estimates and forecast, 2017 - 2027, (USD Million)
10.3.10.2. U.K. Research Antibodies Market estimates and forecast By Product, 2017 -2027, (USD Million)
10.3.10.3. U.K. Research Antibodies Market estimates and forecast by Antibody Type, 2017 -2027, (USD Million)
10.3.10.4. U.K. Research Antibodies Market estimates and forecast by Technology, 2017 -2027, (USD Million)
10.3.10.5. U.K. Research Antibodies Market estimates and forecast by Application, 2017 -2027, (USD Million)
10.3.10.6. U.K. Research Antibodies Market estimates and forecast by End-Users, 2017 -2027, (USD Million)
10.3.11. France
10.3.11.1. France Research Antibodies Market estimates and forecast, 2017 - 2027, (USD Million)
10.3.11.2. France Research Antibodies Market estimates and forecast By Product, 2017 -2027, (USD Million)
10.3.11.3. France Research Antibodies Market estimates and forecast by Antibody Type, 2017 -2027, (USD Million)
10.3.11.4. France Research Antibodies Market estimates and forecast by Technology, 2017 -2027, (USD Million)
10.3.11.5. France Research Antibodies Market estimates and forecast by Application, 2017 -2027, (USD Million)
10.3.11.6. France Research Antibodies Market estimates and forecast by End-Users, 2017 -2027, (USD Million)
10.3.12. Benelux
10.3.12.1. Benelux Research Antibodies Market estimates and forecast, 2017 - 2027, (USD Million)
10.3.12.2. Benelux Research Antibodies Market estimates and forecast By Product, 2017 -2027, (USD Million)
10.3.12.3. Benelux Research Antibodies Market estimates and forecast by Antibody Type, 2017 -2027, (USD Million)
10.3.12.4. Benelux Research Antibodies Market estimates and forecast by Technology, 2017 -2027, (USD Million)
10.3.12.5. Benelux Research Antibodies Market estimates and forecast by Application, 2017 -2027, (USD Million)
10.3.12.6. Benelux Research Antibodies Market estimates and forecast by End-Users, 2017 -2027, (USD Million)
10.3.13. Rest of Europe
10.3.13.1. Rest of Europe Research Antibodies Market estimates and forecast, 2017 - 2027, (USD Million)
10.3.13.2. Rest of Europe Research Antibodies Market estimates and forecast By Product, 2017 -2027, (USD Million)
10.3.13.3. Rest of Europe Research Antibodies Market estimates and forecast by Antibody Type, 2017 -2027, (USD Million)
10.3.13.4. Rest of Europe Research Antibodies Market estimates and forecast by Technology, 2017 -2027, (USD Million)
10.3.13.5. Rest of Europe Research Antibodies Market estimates and forecast by Application, 2017 -2027, (USD Million)
10.3.13.6. Rest of Europe Research Antibodies Market estimates and forecast by End-Users, 2017 -2027, (USD Million)
10.4. Asia-Pacific
10.4.1. Covid-19 Impact Analysis, 2020-2021
10.4.2. Global Recession Influence, 2020-2021
10.4.3. Asia-Pacific Research Antibodies Market estimates and forecast, 2017 - 2027, (USD Million)
10.4.4. Asia Pacific Research Antibodies Market estimates and forecast By Product, 2017 -2027, (USD Million)
10.4.5. Asia Pacific Research Antibodies Market estimates and forecast by Antibody Type, 2017 -2027, (USD Million)
10.4.6. Asia Pacific Research Antibodies Market estimates and forecast by Technology, 2017 -2027, (USD Million)
10.4.7. Asia Pacific Research Antibodies Market estimates and forecast by Application, 2017 -2027, (USD Million)
10.4.8. Asia Pacific Research Antibodies Market estimates and forecast by End-Users, 2017 -2027, (USD Million)
10.4.9. China
10.4.9.1. China Research Antibodies Market estimates and forecast, 2017 - 2027, (USD Million)
10.4.9.2. China Research Antibodies Market estimates and forecast By Product, 2017 -2027, (USD Million)
10.4.9.3. China Research Antibodies Market estimates and forecast by Antibody Type, 2017 -2027, (USD Million)
10.4.9.4. China Research Antibodies Market estimates and forecast by Technology, 2017 -2027, (USD Million)
10.4.9.5. China Research Antibodies Market estimates and forecast by Application, 2017 -2027, (USD Million)
10.4.9.6. China Research Antibodies Market estimates and forecast by End-Users, 2017 -2027, (USD Million)
10.4.10. India
10.4.10.1. India Research Antibodies Market estimates and forecast, 2017 - 2027, (USD Million)
10.4.10.2. India Research Antibodies Market estimates and forecast By Product, 2017 -2027, (USD Million)
10.4.10.3. India Research Antibodies Market estimates and forecast by Antibody Type, 2017 -2027, (USD Million)
10.4.10.4. India Research Antibodies Market estimates and forecast by Technology, 2017 -2027, (USD Million)
10.4.10.5. India Research Antibodies Market estimates and forecast by Application, 2017 -2027, (USD Million)
10.4.10.6. India Research Antibodies Market estimates and forecast by End-Users, 2017 -2027, (USD Million)
10.4.11. Japan
10.4.11.1. Japan Research Antibodies Market estimates and forecast, 2017 - 2027, (USD Million)
10.4.11.2. Japan Research Antibodies Market estimates and forecast By Product, 2017 -2027, (USD Million)
10.4.11.3. Japan Research Antibodies Market estimates and forecast by Antibody Type, 2017 -2027, (USD Million)
10.4.11.4. Japan Research Antibodies Market estimates and forecast by Technology, 2017 -2027, (USD Million)
10.4.11.5. Japan Research Antibodies Market estimates and forecast by Application, 2017 -2027, (USD Million)
10.4.11.6. Japan Research Antibodies Market estimates and forecast by End-Users, 2017 -2027, (USD Million)
10.4.12. SOUTH KOREA
10.4.12.1. South Korea Research Antibodies Market estimates and forecast, 2017 - 2027, (USD Million)
10.4.12.2. South Korea Research Antibodies Market estimates and forecast By Product, 2017 -2027, (USD Million)
10.4.12.3. South Korea Research Antibodies Market estimates and forecast by Antibody Type, 2017 -2027, (USD Million)
10.4.12.4. South Korea Research Antibodies Market estimates and forecast by Technology, 2017 -2027, (USD Million)
10.4.12.5. South Korea Research Antibodies Market estimates and forecast by Application, 2017 -2027, (USD Million)
10.4.12.6. South Korea Research Antibodies Market estimates and forecast by End-Users, 2017 -2027, (USD Million)
10.4.13. Rest of Asia Pacific
10.4.13.1. Rest of Asia Pacific Research Antibodies Market estimates and forecast, 2017 - 2027, (USD Million)
10.4.13.2. Rest of Asia Pacific Research Antibodies Market estimates and forecast By Product, 2017 -2027, (USD Million)
10.4.13.3. Rest of Asia Pacific Research Antibodies Market estimates and forecast by Antibody Type, 2017 -2027, (USD Million)
10.4.13.4. Rest of Asia Pacific Research Antibodies Market estimates and forecast by Technology, 2017 -2027, (USD Million)
10.4.13.5. Rest of Asia Pacific Research Antibodies Market estimates and forecast by Application, 2017 -2027, (USD Million)
10.4.13.6. Rest of Asia Pacific Research Antibodies Market estimates and forecast by End-Users, 2017 -2027, (USD Million)
10.5. Middle East and Africa
10.5.1. Covid-19 Impact Analysis, 2020-2021
10.5.2. Global Recession Influence, 2020-2021
10.5.3. Middle East and Africa Research Antibodies Market estimates and forecast, 2017 - 2027, (USD Million)
10.5.4. Middle East & Africa Research Antibodies Market estimates and forecast By Product, 2017 -2027, (USD Million)
10.5.5. Middle East & Africa Research Antibodies Market estimates and forecast by Antibody Type, 2017 -2027, (USD Million)
10.5.6. Middle East & Africa Research Antibodies Market estimates and forecast by Technology, 2017 -2027, (USD Million)
10.5.7. Middle East & Africa Research Antibodies Market estimates and forecast by Application, 2017 -2027, (USD Million)
10.5.8. Middle East & Africa Research Antibodies Market estimates and forecast by End-Users, 2017 -2027, (USD Million)
10.5.9. Saudi Arabia
10.5.9.1. Saudi Arabia Research Antibodies Market estimates and forecast, 2017 - 2027, (USD Million)
10.5.9.2. Saudi Arabia Research Antibodies Market estimates and forecast By Product, 2017 -2027, (USD Million)
10.5.9.3. Saudi Arabia Research Antibodies Market estimates and forecast by Antibody Type, 2017 -2027, (USD Million)
10.5.9.4. Saudi Arabia Research Antibodies Market estimates and forecast by Technology, 2017 -2027, (USD Million)
10.5.9.5. Saudi Arabia Research Antibodies Market estimates and forecast by Application, 2017 -2027, (USD Million)
10.5.9.6. Saudi Arabia Research Antibodies Market estimates and forecast by End-Users, 2017 -2027, (USD Million)
10.5.10. UAE
10.5.10.1. UAE Research Antibodies Market estimates and forecast, 2017 - 2027, (USD Million)
10.5.10.2. UAE Research Antibodies Market estimates and forecast By Product, 2017 -2027, (USD Million)
10.5.10.3. UAE Research Antibodies Market estimates and forecast by Antibody Type, 2017 -2027, (USD Million)
10.5.10.4. UAE Research Antibodies Market estimates and forecast by Technology, 2017 -2027, (USD Million)
10.5.10.5. UAE Research Antibodies Market estimates and forecast by Application, 2017 -2027, (USD Million)
10.5.10.6. UAE Research Antibodies Market estimates and forecast by End-Users, 2017 -2027, (USD Million)
10.5.11. Rest of Middle East & Africa
10.5.11.1. Rest of Middle East & Africa Research Antibodies Market estimates and forecast, 2017 - 2027, (USD Million)
10.5.11.2. Rest of Middle East & Africa Research Antibodies Market estimates and forecast By Product, 2017 -2027, (USD Million)
10.5.11.3. Rest of Middle East & Africa Research Antibodies Market estimates and forecast by Antibody Type, 2017 -2027, (USD Million)
10.5.11.4. Rest of Middle East & Africa Research Antibodies Market estimates and forecast by Technology, 2017 -2027, (USD Million)
10.5.11.5. Rest of Middle East & Africa Research Antibodies Market estimates and forecast by Application, 2017 -2027, (USD Million)
10.5.11.6. Rest of Middle East & Africa Research Antibodies Market estimates and forecast by End-Users, 2017 -2027, (USD Million)
10.6. Latin America
10.6.1. Covid-19 Impact Analysis, 2020-2021
10.6.2. Global Recession Influence, 2020-2021
10.6.3. Latin America Research Antibodies Market estimates and forecast, 2017 - 2027, (USD Million)
10.6.4. Latin America Research Antibodies Market estimates and forecast By Product, 2017 -2027, (USD Million)
10.6.5. Latin America Research Antibodies Market estimates and forecast by Antibody Type, 2017 -2027, (USD Million)
10.6.6. Latin America Research Antibodies Market estimates and forecast by Technology, 2017 -2027, (USD Million)
10.6.7. Latin America Research Antibodies Market estimates and forecast by Application, 2017 -2027, (USD Million)
10.6.8. Latin America Research Antibodies Market estimates and forecast by End-Users, 2017 -2027, (USD Million)
10.6.9. Brazil
10.6.9.1. Brazil Research Antibodies Market estimates and forecast, 2017 - 2027, (USD Million)
10.6.9.2. Brazil Research Antibodies Market estimates and forecast By Product, 2017 -2027, (USD Million)
10.6.9.3. Brazil Research Antibodies Market estimates and forecast by Antibody Type, 2017 -2027, (USD Million)
10.6.9.4. Brazil Research Antibodies Market estimates and forecast by Technology, 2017 -2027, (USD Million)
10.6.9.5. Brazil Research Antibodies Market estimates and forecast by End-Users, 2017 -2027, (USD Million)
10.6.9.6. Brazil Research Antibodies Market estimates and forecast by Application, 2017 -2027, (USD Million)
10.6.10. Rest of Latin America
10.6.10.1. Rest of Latin America Research Antibodies Market estimates and forecast, 2017 - 2027, (USD Million)
10.6.10.2. Rest of Latin America Research Antibodies Market estimates and forecast By Product, 2017 -2027, (USD Million)
10.6.10.3. Rest of Latin America Research Antibodies Market estimates and forecast by Antibody Type, 2017 -2027, (USD Million)
10.6.10.4. Rest of Latin America Research Antibodies Market estimates and forecast by Technology, 2017 -2027, (USD Million)
10.6.10.5. Rest of Latin America Research Antibodies Market estimates and forecast by Application, 2017 -2027, (USD Million)
10.6.10.6. Rest of Latin America Research Antibodies Market estimates and forecast by End-Users, 2017 -2027, (USD Million)

Chapter 11. Competitive Landscape
11.1. Market Revenue Share by Manufacturers
11.2. Manufacturing Cost Breakdown Analysis
11.3. Mergers & Acquisitions
11.4. Market positioning
11.5. Strategy Benchmarking
11.6. Customer Mapping
11.7. Vendor Landscape

Chapter 12. Company Profiles
12.1. Becton, Dickinson and Company
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Technology Insights
12.1.4. Strategic Initiatives
12.2. Lonza Group
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Technology Insights
12.2.4. Strategic Initiatives
12.3. Agilent Technologies
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Technology Insights
12.3.4. Strategic Initiatives
12.4. Abcam PLC
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Technology Insights
12.4.4. Strategic Initiatives
12.5. PerkinElmer, Inc.
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Technology Insights
12.5.4. Strategic Initiatives
12.6. Bio-Rad Laboratories
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Technology Insights
12.6.4. Strategic Initiatives
12.7. Merck Millipore
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Technology Insights
12.7.4. Strategic Initiatives
12.8. F. Hoffmann-La Roche AG
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Technology Insights
12.8.4. Strategic Initiatives
12.9. Thermo Fisher Scientific
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Technology Insights
12.9.4. Strategic Initiatives
12.10. Cell Signaling Technology, Inc.
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Technology Insights
12.10.4. Strategic Initiatives
Note: Product cover images may vary from those shown
  • Becton
  • Dickinson Co.pany
  • Lonza Group
  • Agilent Technologies
  • Abcam PLC
  • PerkinElmer Inc.
  • Bio-Rad Laboratories
  • Merck Millipore
  • F.Hoffmann-La Roche AG
  • Thermo Fisher Scientific
  • Cell Signaling Technology Inc.,
Note: Product cover images may vary from those shown
Adroll
adroll